Andrews Nancy C
Harvard Medical School, Boston, MA 02115, USA.
Postgrad Med. 2004 Nov;116(5 Suppl Anemia):17-22. doi: 10.3810/pgm.11.2004.suppl36.250.
Anemia of chronic disease (ACD) is a prevalent condition commonly observed in patients with chronic infections, cancer, trauma, and inflammatory disorders. In this article, Dr Andrews examines new research findings that enhance the understanding of the pathophysiologic mechanisms of ACD. After a brief review of iron homeostasis and a look at ACD in a historical context, she explores the significance of hepcidin, a recently discovered hormone involved in iron metabolism, and discusses a new hypothesis that connects hepcidin to the pathogenesis of ACD. Dr Andrews also examines the link between ACD and hereditary hemochromatosis, 2 disorders that on the surface may seem quite different but have in common the involvement of hepcidin in their pathogenesis.
慢性病性贫血(ACD)是一种常见病症,在慢性感染、癌症、创伤及炎症性疾病患者中普遍存在。在本文中,安德鲁斯博士审视了新的研究发现,这些发现增进了人们对ACD病理生理机制的理解。在简要回顾铁稳态并从历史角度审视ACD之后,她探究了铁调素(一种最近发现的参与铁代谢的激素)的重要性,并讨论了一个将铁调素与ACD发病机制相联系的新假说。安德鲁斯博士还研究了ACD与遗传性血色素沉着症之间的联系,这两种病症表面上可能差异很大,但在发病机制中都有铁调素的参与这一点上是相同的。